Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000914475-24-000211
Filing Date
2024-10-30
Accepted
2024-10-30 07:04:11
Documents
94
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nbix-20240930.htm   iXBRL 10-Q 1090281
2 EX-3.2 exhibit32-bylawsasamende.htm EX-3.2 129782
3 EX-10.1 exhibit101-2011equityinc.htm EX-10.1 102215
4 EX-10.2 exhibit102-2020equityinc.htm EX-10.2 121757
5 EX-10.3 exhibit103-formofoptiong.htm EX-10.3 17059
6 EX-31.1 q3-2024xexhibit311.htm EX-31.1 10248
7 EX-31.2 q3-2024xexhibit312.htm EX-31.2 10260
8 EX-32 q3-2024xexhibit32.htm EX-32 9875
14 GRAPHIC exhibit101-2011equityinc001.jpg GRAPHIC 1051456
15 GRAPHIC exhibit101-2011equityinc002.jpg GRAPHIC 1224185
16 GRAPHIC exhibit101-2011equityinc003.jpg GRAPHIC 1214678
17 GRAPHIC exhibit101-2011equityinc004.jpg GRAPHIC 1095497
18 GRAPHIC exhibit101-2011equityinc005.jpg GRAPHIC 1249124
19 GRAPHIC exhibit101-2011equityinc006.jpg GRAPHIC 1070219
20 GRAPHIC exhibit101-2011equityinc007.jpg GRAPHIC 1089047
21 GRAPHIC exhibit101-2011equityinc008.jpg GRAPHIC 175436
22 GRAPHIC exhibit102-2020equityinc001.jpg GRAPHIC 1087033
23 GRAPHIC exhibit102-2020equityinc002.jpg GRAPHIC 1151611
24 GRAPHIC exhibit102-2020equityinc003.jpg GRAPHIC 1184371
25 GRAPHIC exhibit102-2020equityinc004.jpg GRAPHIC 1115538
26 GRAPHIC exhibit102-2020equityinc005.jpg GRAPHIC 1195470
27 GRAPHIC exhibit102-2020equityinc006.jpg GRAPHIC 1026888
28 GRAPHIC exhibit102-2020equityinc007.jpg GRAPHIC 1140075
29 GRAPHIC exhibit102-2020equityinc008.jpg GRAPHIC 1209962
30 GRAPHIC exhibit102-2020equityinc009.jpg GRAPHIC 633457
31 GRAPHIC exhibit103-formofoptiong001.jpg GRAPHIC 790499
32 GRAPHIC exhibit103-formofoptiong002.jpg GRAPHIC 593073
33 GRAPHIC exhibit32-bylawsasamende001.jpg GRAPHIC 521280
34 GRAPHIC exhibit32-bylawsasamende002.jpg GRAPHIC 1056269
35 GRAPHIC exhibit32-bylawsasamende003.jpg GRAPHIC 1331523
36 GRAPHIC exhibit32-bylawsasamende004.jpg GRAPHIC 1212199
37 GRAPHIC exhibit32-bylawsasamende005.jpg GRAPHIC 1083603
38 GRAPHIC exhibit32-bylawsasamende006.jpg GRAPHIC 1196337
39 GRAPHIC exhibit32-bylawsasamende007.jpg GRAPHIC 1096404
40 GRAPHIC exhibit32-bylawsasamende008.jpg GRAPHIC 1011090
41 GRAPHIC exhibit32-bylawsasamende009.jpg GRAPHIC 1085831
42 GRAPHIC exhibit32-bylawsasamende010.jpg GRAPHIC 632720
43 GRAPHIC nbix-20240930_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-24-000211.txt   46811926

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20240930.xsd EX-101.SCH 34783
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nbix-20240930_cal.xml EX-101.CAL 83738
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nbix-20240930_def.xml EX-101.DEF 130605
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20240930_lab.xml EX-101.LAB 521201
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20240930_pre.xml EX-101.PRE 331109
96 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20240930_htm.xml XML 713151
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22705 | Film No.: 241407417
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)